We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$52.8B
AUM Growth
+$12.4B
(+31%)
Cap. Flow
+$6.6B
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
10.83%
Holding
4,679
New
953
Increased
1,510
Reduced
1,399
Closed
740
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$763M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$336M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$246M |
| 4 |
Apple
AAPL
|
+$203M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$158M |
| 2 |
Sherwin-Williams
SHW
|
+$155M |
| 3 |
Goldman Sachs
GS
|
+$139M |
| 4 |
Bank of America
BAC
|
+$127M |
| 5 |
Royal Caribbean
RCL
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.3% |
| 2 | Consumer Discretionary | 7.9% |
| 3 | Healthcare | 4.86% |
| 4 | Financials | 4.75% |
| 5 | Industrials | 3.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Epsilon Energy
EPSN
$176M
| $59.9K | ﹤0.01% |
11,800
+527
| +5% | +$2.81K |
|
3827
Cadiz
CDZI
$266M
| $59.9K | ﹤0.01% |
+21,397
| New | +$64.5K |
|
3828
Sutro Biopharma
STRO
$379M
| $59.6K | ﹤0.01% |
+1,390
| New | +$44.1K |
|
3829
electroCore
ECOR
$51.4M
| $58.2K | ﹤0.01% |
+10,054
| New | +$57.8K |
|
|
QVCGA
3830
DELISTED
QVC Group Inc Series A
QVCGA
| $58K | ﹤0.01% |
1,324
+861
| +186% | +$29.5K |
|
3831
Retractable Technologies
RVP
$20.4M
| $57.9K | ﹤0.01% |
52,205
+9,795
| +23% | +$11K |
|
3832
Atossa Therapeutics
ATOS
$22.8M
| $55.5K | ﹤0.01% |
+4,204
| New | +$45.4K |
|
|
OMIC
3833
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $55.3K | ﹤0.01% |
4,003
-470
| -11% | -$5.56K |
|
3834
X4 Pharmaceuticals
XFOR
$363M
| $54.3K | ﹤0.01% |
+2,159
| New | +$52.5K |
|
3835
GrafTech
EAF
$194M
| $53.7K | ﹤0.01% |
2,452
-14,249
| -85% | -$403K |
|
3836
Hydrofarm Holdings
HYFM
$3.13M
| $53.4K | ﹤0.01% |
+5,819
| New | +$56.1K |
|
3837
Adicet Bio
ACET
$72.8M
| $53.4K | ﹤0.01% |
1,765
+114
| +7% | +$2.49K |
|
|
LICY
3838
DELISTED
Li-Cycle Holdings Corp.
LICY
| $53K | ﹤0.01% |
+11,326
| New | +$129K |
|
3839
LanzaTech
LNZA
$61.3M
| $52.2K | ﹤0.01% |
+104
| New | +$45.7K |
|
|
NTBL
3840
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $51.9K | ﹤0.01% |
27,167
+20,675
| +318% | +$81.4K |
|
3841
Mizuho Financial
MFG
$129B
| $51.3K | ﹤0.01% |
+14,919
| New | +$50.7K |
|
3842
Planet Labs
PL
$7.3B
| $50.7K | ﹤0.01% |
20,526
-40,372
| -66% | -$95.5K |
|
|
AFMD
3843
DELISTED
Affimed
AFMD
| $50.2K | ﹤0.01% |
8,028
+6,186
| +336% | +$25.7K |
|
3844
Abeona Therapeutics
ABEO
$345M
| $50.1K | ﹤0.01% |
+10,000
| New | +$44K |
|
3845
Rayonier Advanced Materials
RYAM
$565M
| $49.8K | ﹤0.01% |
12,293
-225,965
| -95% | -$743K |
|
3846
Bakkt Inc
BKKT
$333M
| $49.7K | ﹤0.01% |
892
+290
| +48% | +$10K |
|
|
GTHX
3847
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $49.5K | ﹤0.01% |
16,218
+3,403
| +27% | +$6.39K |
|
|
KNDI
3848
Kandi Technologies Group
KNDI
$65.3M
| $48.6K | ﹤0.01% |
+17,340
| New | +$53.1K |
|
|
LAZR
3849
CALL
DELISTED
Luminar Technologies
LAZR
| $47.2K | ﹤0.01% |
933
| – | – |
|
|
GRTS
3850
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $47.1K | ﹤0.01% |
23,085
-29,855
| -56% | -$54.5K |
|
Similar funds
Squarepoint's Q4 2023 Portfolio in Review
As of Q4 2023, Squarepoint held 4,679 positions worth $52.8B, up 31% from $40.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $6.6B of net new capital in Q4 2023, opening 953 new positions and adding to 1,510 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 550,000 shares worth $263M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Intuit, an estimated $158M trimmed.
- Squarepoint's largest Q4 2023 buy was iShares Core S&P 500 ETF: 550,000 shares worth $263M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $763M increase.
- Squarepoint's biggest Q4 2023 reduction was Intuit, cutting an estimated $158M.
- Squarepoint fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2023, selling an estimated $97.9M.
- Squarepoint's ten largest holdings make up 11% of its $52.8B portfolio in Q4 2023.
- Squarepoint opened 953 new positions and closed 740 in Q4 2023.
- Squarepoint's portfolio value rose 31% quarter-over-quarter to $52.8B.
Based on Squarepoint's 13F filing for Q4 2023, filed 14 Feb 2024.